Novocure Historical Income Statement
| NVCR Stock | USD 12.74 0.50 4.08% |
Historical analysis of Novocure income statement accounts such as Selling And Marketing Expenses of 238.1 M can show how well Novocure performed in making a profits. Evaluating Novocure income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Novocure's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Novocure latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Novocure is a good buy for the upcoming year.
Novocure |
About Novocure Income Statement Analysis
Novocure Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Novocure shareholders. The income statement also shows Novocure investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Novocure Income Statement Chart
Novocure Income Statement is one of the three primary financial statements used for reporting Novocure's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Novocure revenue and expense. Novocure Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Novocure's Selling And Marketing Expenses is relatively stable compared to the past year. As of 05/02/2024, Research Development is likely to grow to about 234.2 M, while Interest Expense is likely to drop slightly above 3.2 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts Novocure generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Novocure minus its cost of goods sold. It is profit before Novocure operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most accounts from Novocure's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Novocure current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.At this time, Novocure's Selling And Marketing Expenses is relatively stable compared to the past year. As of 05/02/2024, Research Development is likely to grow to about 234.2 M, while Interest Expense is likely to drop slightly above 3.2 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 3.4M | 3.3M | 3.3M | 3.2M | Depreciation And Amortization | 10.3M | 10.6M | 11.0M | 7.8M |
Novocure income statement Correlations
Click cells to compare fundamentals
Novocure Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Novocure income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 8.5M | 9.2M | 10.3M | 10.6M | 11.0M | 7.8M | |
| Interest Expense | 13.7M | 13.1M | 3.4M | 3.3M | 3.3M | 3.2M | |
| Selling General Administrative | 87.9M | 107.4M | 126.1M | 132.8M | 164.1M | 87.6M | |
| Selling And Marketing Expenses | 96.7M | 118.0M | 137.1M | 173.7M | 226.8M | 238.1M | |
| Total Revenue | 351.3M | 494.4M | 535.0M | 537.8M | 509.3M | 299.5M | |
| Gross Profit | 262.7M | 387.9M | 420.2M | 423.0M | 381.1M | 222.2M | |
| Other Operating Expenses | 352.2M | 464.0M | 579.4M | 627.4M | 742.2M | 376.9M | |
| Operating Income | (914K) | 21.3M | (44.3M) | (89.5M) | (232.9M) | (221.2M) | |
| Net Income From Continuing Ops | (7.2M) | 19.8M | (58.4M) | (92.5M) | (207.0M) | (196.7M) | |
| Ebit | (914K) | 21.3M | (44.3M) | (89.5M) | (187.6M) | (178.2M) | |
| Research Development | 79.0M | 132.0M | 201.3M | 206.1M | 223.1M | 234.2M | |
| Ebitda | 7.5M | 30.4M | (34.1M) | (78.9M) | (176.7M) | (167.8M) | |
| Cost Of Revenue | 88.6M | 106.5M | 114.9M | 114.9M | 128.3M | 77.3M | |
| Total Operating Expenses | 263.6M | 357.5M | 464.5M | 512.5M | 613.9M | 644.6M | |
| Income Before Tax | (8.8M) | 18.1M | (52.1M) | (81.8M) | (191.7M) | (182.2M) | |
| Total Other Income Expense Net | (7.9M) | (3.1M) | (7.7M) | 7.7M | (797K) | (836.9K) | |
| Net Income Applicable To Common Shares | (7.2M) | 19.8M | (58.4M) | (92.5M) | (106.4M) | (111.7M) | |
| Net Income | (7.2M) | 19.8M | (58.4M) | (92.5M) | (207.0M) | (196.7M) | |
| Income Tax Expense | (1.6M) | (1.7M) | 6.3M | 10.7M | 15.3M | 16.1M | |
| Tax Provision | (1.6M) | (1.7M) | 6.3M | 10.7M | 15.3M | 9.1M | |
| Interest Income | 4.4M | 1.8M | 791K | 11.0M | 19.6M | 20.6M | |
| Net Interest Income | (7.5M) | (14.9M) | (3.7M) | 11.2M | 41.9M | 44.0M | |
| Reconciled Depreciation | 8.5M | 9.2M | 10.3M | 10.6M | 11.0M | 10.4M |
Novocure Investors Sentiment
The influence of Novocure's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Novocure. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Novocure's public news can be used to forecast risks associated with an investment in Novocure. The trend in average sentiment can be used to explain how an investor holding Novocure can time the market purely based on public headlines and social activities around Novocure. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Novocure's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Novocure's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Novocure's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Novocure.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novocure in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novocure's short interest history, or implied volatility extrapolated from Novocure options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.Note that the Novocure information on this page should be used as a complementary analysis to other Novocure's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Novocure Stock analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Novocure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novocure. If investors know Novocure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novocure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share (1.95) | Revenue Per Share 4.787 | Quarterly Revenue Growth 0.042 | Return On Assets (0.12) |
The market value of Novocure is measured differently than its book value, which is the value of Novocure that is recorded on the company's balance sheet. Investors also form their own opinion of Novocure's value that differs from its market value or its book value, called intrinsic value, which is Novocure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novocure's market value can be influenced by many factors that don't directly affect Novocure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novocure's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novocure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novocure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.